Because Takeda doesn't want to pay out the severance and they made it a contingency of getting the drug. Also, it allows Novartis to hand pick the few valuable people they want to keep around.
There's no way they're retaining 300 redundant reps for months and months, it's a waste of money. They'll be analyzing the business during the next 60-90 days so cuts can be made ASAP
